iaccelereate.tech

iaccelerate.tech

VCMatch tracks iaccelereate.tech as an investor focused on Foodtech and Biotech companies, Pre-Seed and Seed rounds, and United States, Asia, and Europe markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Pre-Seed, Seed

Focus Areas

Foodtech, Biotech

Geography

United States, Asia, and Europe

Investment Thesis

This firm positions itself as a focused, hands-on virtual accelerator for FoodTech and Synthetic Biology startups, emphasizing rapid, tailored support to move science to market. The website states they are “A Virtual Accelerator for pioneers in FoodTech and SynBio Where Ideas Reach their Full Potential,” and that “we will help a startup find market, communicate their technology, raise funds and establish a quality offering to investors.” Their approach combines technical domain expertise (founder experience with IndieBio and “100+ startup investments”) with intensive advisor access and practical business support (pitch, product, investor relationships, board diligence, culture) to drive “global impact.”

Is iaccelereate.tech right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

iaccelereate.tech is most relevant for founders raising Pre-Seed and Seed rounds in Foodtech and Biotech, especially across United States, Asia, and Europe.

Focus statement

Focused on FoodTech and SynBio startups, acting as a technology-focused virtual accelerator and "Trusted Technology Partner" that helps companies find market fit, raise follow-on funding, and scale.

Value Add

Vertical specialization in FoodTech and Synthetic Biology (explicitly branded as "A Virtual Accelerator for pioneers in FoodTech and SynBio").
Founder and team depth in the space: Ron Shigeta PhD (Co-Founder @ IndieBio) with "100+ startup investments" and a "$3+B Market Cap Career Portfolio."
Tailored, high-touch model: site claims "iAccelerate takes a tailors their approach with each client" and offers "open 1:1 access" with "Up 120 hours of face time advising."
Demonstrated outcomes and metrics: "85% follow on beyond 6 months," "Cumulative $210M Market Cap," "$42M raised follow on Funds," and relationships with accelerators ("8 YC companies").
Extensive network of domain advisors and partners (listed advisors from pharma, food execs, and investors) and operational help from lab build to marketing and investment.
Global reach: portfolio includes companies from "US, Asia, Europe."